Chromosome 2 sequence of the human malaria parasite Plasmodium falciparum.
Genome sequence of the human malaria parasite Plasmodium falciparum.
Sequence of Plasmodium falciparum chromosomes 1, 3-9 and 13.
Aminobenzosuberone derivatives as PfA-M1 inhibitors: Molecular recognition and antiplasmodial evaluation.
Identification and Validation of a Potent Dual Inhibitor of the P. falciparum M1 and M17 Aminopeptidases Using Virtual Screening.
The Anp32 family of proteins containing leucine-rich repeats.
Functional dissection of proliferating-cell nuclear antigens (1 and 2) in human malarial parasite Plasmodium falciparum: possible involvement in DNA replication and DNA damage response.
Identification of a second proliferating cell nuclear antigen in the human malarial pathogen Plasmodium falciparum.
Molecular characterization and expression of an alternate proliferating cell nuclear antigen homologue, PfPCNA2, in Plasmodium falciparum.
Sir2 paralogues cooperate to regulate virulence genes and antigenic variation in Plasmodium falciparum.
The complete nucleotide sequence of chromosome 3 of Plasmodium falciparum.
Cryo-EM structure of the Plasmodium falciparum 80S ribosome bound to the anti-protozoan drug emetine.
Dynamical features of the Plasmodium falciparum ribosome during translation.
Deciphering the mechanism of potent peptidomimetic inhibitors targeting plasmepsins - biochemical and structural insights.
Plasmodium food vacuole plasmepsins are activated by falcipains.
Protein complex directs hemoglobin-to-hemozoin formation in Plasmodium falciparum.
The role of Plasmodium falciparum food vacuole plasmepsins.
Trafficking of plasmepsin II to the food vacuole of the malaria parasite Plasmodium falciparum.
Rapid identification of malaria vaccine candidates based on alpha-helical coiled coil protein motif.
The N-terminal RNA Recognition Motif of PfSR1 Confers Semi-specificity for Pyrimidines during RNA Recognition.
Plasmodium Ape1 is a multifunctional enzyme in mitochondrial base excision repair and is required for efficient transition from liver to blood stage infection.
Structural Analysis of the Plasmodial Proteins ZNHIT3 and NUFIP1 Provides Insights into the Selectivity of a Conserved Interaction.
Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase: a unique bifunctional enzyme from Plasmodium falciparum.
Construction of a Plasmodium falciparum Rab-interactome identifies CK1 and PKA as Rab-effector kinases in malaria parasites.
Plasmodium Rab5b is secreted to the cytoplasmic face of the tubovesicular network in infected red blood cells together with N-acylated adenylate kinase 2.
Plasmodium falciparum Rab5B is an N-terminally myristoylated Rab GTPase that is targeted to the parasite's plasma and food vacuole membranes.
Rab5b-Associated Arf1 GTPase Regulates Export of N-Myristoylated Adenylate Kinase 2 From the Endoplasmic Reticulum in Plasmodium falciparum.
The structure of Plasmodium falciparum 3D7_0606800 reveals a bi-lobed architecture that supports re-annotation as a Venus Flytrap protein.
The structure of the PA28-20S proteasome complex from Plasmodium falciparum and implications for proteostasis.
Mefloquine targets the Plasmodium falciparum 80S ribosome to inhibit protein synthesis.
Structural basis for RIFIN-mediated activation of LILRB1 in malaria.
Characterization of Plasmodium falciparum 6-Phosphogluconate Dehydrogenase as an Antimalarial Drug Target.
An EGF-like protein forms a complex with PfRh5 and is required for invasion of human erythrocytes by Plasmodium falciparum.
Essential Role of the PfRh5/PfRipr/CyRPA Complex during Plasmodium falciparum Invasion of Erythrocytes.
Identification of Plasmodium falciparum reticulocyte binding protein homologue 5-interacting protein, PfRipr, as a highly conserved blood-stage malaria vaccine candidate.
Multiprotein complex between the GPI-anchored CyRPA with PfRH5 and PfRipr is crucial for Plasmodium falciparum erythrocyte invasion.
P113 is a merozoite surface protein that binds the N terminus of Plasmodium falciparum RH5.
Structure of Plasmodium falciparum Rh5-CyRPA-Ripr invasion complex.
Biochemical characterization of Plasmodium falciparum Sir2, a NAD+-dependent deacetylase.
Differential association of Orc1 and Sir2 proteins to telomeric domains in Plasmodium falciparum.
Nicotinamide inhibits Plasmodium falciparum Sir2 activity in vitro and parasite growth.
Plasmodium falciparum Sir2 is an NAD+-dependent deacetylase and an acetyllysine-dependent and acetyllysine-independent NAD+ glycohydrolase.
Plasmodium falciparum Sir2: an unusual sirtuin with dual histone deacetylase and ADP-ribosyltransferase activity.
Plasmodium falciparum Sir2A preferentially hydrolyzes medium and long chain fatty acyl lysine.
Reversible binding of zinc in Plasmodium falciparum Sir2: structure and activity of the apoenzyme.
Telomeric heterochromatin propagation and histone acetylation control mutually exclusive expression of antigenic variation genes in malaria parasites.
The role of N-terminus of Plasmodium falciparum ORC1 in telomeric localization and var gene silencing.
Functional dissection of the catalytic carboxyl-terminal domain of origin recognition complex subunit 1 (PfORC1) of the human malaria parasite Plasmodium falciparum.
Plasmodium falciparum origin recognition complex subunit 5: functional characterization and role in DNA replication foci formation.
Role of tyrosine residue (Y213) in nuclear retention of PCNA1 in human malaria parasite Plasmodium falciparum.
Structural characterization and inhibition of the Plasmodium Atg8-Atg3 interaction.
Active site coupling in Plasmodium falciparum GMP synthetase is triggered by domain rotation.
Tertiary and Quaternary Structure Organization in GMP Synthetases: Implications for Catalysis.
Male-specific expression of the paralog of malaria transmission-blocking target antigen Pfs230, PfB0400w.
The Plasmodium falciparum male gametocyte protein P230p, a paralog of P230, is vital for ookinete formation and mosquito transmission.
Distorting malaria peptide backbone structure to enable fitting into MHC class II molecules renders modified peptides immunogenic and protective.
Evaluation of two long synthetic merozoite surface protein 2 peptides as malaria vaccine candidates.
Sequential processing of merozoite surface proteins during and after erythrocyte invasion by Plasmodium falciparum.
Solution conformation, backbone dynamics and lipid interactions of the intrinsically unstructured malaria surface protein MSP2.
Structural basis for epitope masking and strain specificity of a conserved epitope in an intrinsically disordered malaria vaccine candidate.
Structural diversity in the 45-kilodalton merozoite surface antigen of Plasmodium falciparum.
Structure and Characterisation of a Key Epitope in the Conserved C-Terminal Domain of the Malaria Vaccine Candidate MSP2.
Target Elucidation by Cocrystal Structures of NADH-Ubiquinone Oxidoreductase of Plasmodium falciparum (PfNDH2) with Small Molecule To Eliminate Drug-Resistant Malaria.
Gift from Nature: CyclomarinA Kills Mycobacteria and Malaria Parasites by Distinct Modes of Action.
Gift from Nature: Cyclomarin A Kills Mycobacteria and Malaria Parasites by Distinct Modes of Action.
Structural basis of LAIR1 targeting by polymorphic Plasmodium RIFINs.
The protein kinase CK2 catalytic domain from Plasmodium falciparum: crystal structure, tyrosine kinase activity and inhibition.
Structure-activity relationships of C6-uridine derivatives targeting plasmodia orotidine monophosphate decarboxylase.
Structure-activity relationships of orotidine-5'-monophosphate decarboxylase inhibitors as anticancer agents.
Design of proteasome inhibitors with oral efficacy in vivo against Plasmodium falciparum and selectivity over the human proteasome.
Plasmodium falciparum SSB tetramer wraps single-stranded DNA with similar topology but opposite polarity to E. coli SSB.
Crystal structures of IspF from Plasmodium falciparum and Burkholderia cenocepacia: comparisons inform antimicrobial drug target assessment.
Full-length Plasmodium falciparum myosin A and essential light chain PfELC structures provide new anti-malarial targets.
Structural role of essential light chains in the apicomplexan glideosome.
Structural and Functional Characterization of Plasmodium falciparum Nicotinic Acid Mononucleotide Adenylyltransferase.
A unique phosphatidylinositol 4-phosphate 5-kinase is activated by ADP-ribosylation factor in Plasmodium falciparum.
Detection of the in vitro modulation of Plasmodium falciparum Arf1 by Sec7 and ArfGAP domains using a colorimetric plate-based assay.
Structure of Plasmodium falciparum ADP-ribosylation factor 1.
Elongation factor Tu prevents misediting of Gly-tRNA(Gly) caused by the design behind the chiral proofreading site of D-aminoacyl-tRNA deacylase.
Ligand-bound structures provide atomic snapshots for the catalytic mechanism of D-amino acid deacylase.
Mechanism of chiral proofreading during translation of the genetic code.
Role of D-aminoacyl-tRNA deacylase beyond chiral proofreading as a cellular defense against glycine mischarging by AlaRS.
Structure of D-tyrosyl-tRNATyr deacylase using home-source Cu Kalpha and moderate-quality iodide-SAD data: structural polymorphism and HEPES-bound enzyme states.
Structural and functional basis for inhibition of erythrocyte invasion by antibodies that target Plasmodium falciparum EBA-175.
Structure-Guided Identification of a Family of Dual Receptor-Binding PfEMP1 that Is Associated with Cerebral Malaria.
Kinetic, inhibition and structural studies on 3-oxoacyl-ACP reductase from Plasmodium falciparum, a key enzyme in fatty acid biosynthesis.
Cyclic nucleotide-specific phosphodiesterases of Plasmodium falciparum: PfPDEalpha, a non-essential cGMP-specific PDE that is an integral membrane protein.
Phosphodiesterase beta is the master regulator of cAMP signalling during malaria parasite invasion.
Functional analysis of Plasmodium falciparum parasitophorous vacuole membrane protein (Pfs16) during gametocytogenesis and gametogenesis by targeted gene disruption.
Plasmodium falciparum: mRNA co-expression and protein co-localisation of two gene products upregulated in early gametocytes.
Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum.
Crystal structure of PfRh5, an essential P. falciparum ligand for invasion of human erythrocytes.
Human Antibodies that Slow Erythrocyte Invasion Potentiate Malaria-Neutralizing Antibodies.
One-step design of a stable variant of the malaria invasion protein RH5 for use as a vaccine immunogen.
P. falciparum RH5-Basigin interaction induces changes in the cytoskeleton of the host RBC.
PfRH5: a novel reticulocyte-binding family homolog of plasmodium falciparum that binds to the erythrocyte, and an investigation of its receptor.
RH5-Basigin interaction plays a major role in the host tropism of Plasmodium falciparum.
Reticulocyte-binding protein homologue 5 - an essential adhesin involved in invasion of human erythrocytes by Plasmodium falciparum.
A novel inhibitor of Plasmodium falciparum spermidine synthase: a twist in the tail.
Crystal structure of Plasmodium falciparum spermidine synthase in complex with the substrate decarboxylated S-adenosylmethionine and the potent inhibitors 4MCHA and AdoDATO.
Genome-scale protein expression and structural biology of Plasmodium falciparum and related Apicomplexan organisms.
Three-dimensional structures of Plasmodium falciparum spermidine synthase with bound inhibitors suggest new strategies for drug design.
Comprehensive histone phosphorylation analysis and identification of Pf14-3-3 protein as a histone H3 phosphorylation reader in malaria parasites.
Molecular dynamics simulations and biochemical characterization of Pf14-3-3 and PfCDPK1 interaction towards its role in growth of human malaria parasite.
Phosphorylation-Dependent Assembly of a 14-3-3 Mediated Signaling Complex during Red Blood Cell Invasion by Plasmodium falciparum Merozoites.
A nonpeptidyl molecule modulates apoptosis-like cell death by inhibiting P. falciparum metacaspase-2.
Biochemical characterization of unusual cysteine protease of P. falciparum, metacaspase-2 (MCA-2).
Structure of a putative ClpS N-end rule adaptor protein from the malaria pathogen Plasmodium falciparum.
A potent malaria transmission blocking vaccine based on codon harmonized full length Pfs48/45 expressed in Escherichia coli.
Correctly folded Pfs48/45 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in mice.
Further characterization of interactions between gamete surface antigens of Plasmodium falciparum.
Structural basis for recognition of the malaria vaccine candidate Pfs48/45 by a transmission blocking antibody.
Structural delineation of potent transmission-blocking epitope I on malaria antigen Pfs48/45.
Features of apoptosis in Plasmodium falciparum erythrocytic stage through a putative role of PfMCA1 metacaspase-like protein.
Plasmodium falciparum metacaspase PfMCA-1 triggers a z-VAD-fmk inhibitable protease to promote cell death.
An essential pentatricopeptide repeat protein in the apicomplexan remnant chloroplast.
Molecular characterization, heterologous expression and kinetic analysis of recombinant Plasmodium falciparum thymidylate kinase.
Mutational, inhibitory and microcalorimetric analyses of Plasmodium falciparum TMP kinase. Implications for drug discovery.
Structural basis for the efficient phosphorylation of AZT-MP (3'-azido-3'-deoxythymidine monophosphate) and dGMP by Plasmodium falciparum type I thymidylate kinase.
Synthesis and evaluation of alpha-thymidine analogues as novel antimalarials.
dGMP Binding to Thymidylate Kinase from Plasmodium falciparum Shows Half-Site Binding and Induces Protein Dynamics at the Dimer Interface.
Histone lysine methyltransferases and demethylases in Plasmodium falciparum.
PfSETvs methylation of histone H3K36 represses virulence genes in Plasmodium falciparum.
A conserved molecular motor drives cell invasion and gliding motility across malaria life cycle stages and other apicomplexan parasites.
Binding of aldolase and glyceraldehyde-3-phosphate dehydrogenase to the cytoplasmic tails of Plasmodium falciparum merozoite duffy binding-like and reticulocyte homology ligands.
Inhibition by stabilization: targeting the Plasmodium falciparum aldolase-TRAP complex.
Plasmodium falciparum aldolase and the C-terminal cytoplasmic domain of certain apical organellar proteins promote actin polymerization.
The Binding of Plasmodium falciparum Adhesins and Erythrocyte Invasion Proteins to Aldolase Is Enhanced by Phosphorylation.
The structure of chagasin in complex with a cysteine protease clarifies the binding mode and evolution of an inhibitor family.
A sugar phosphatase regulates the methylerythritol phosphate (MEP) pathway in malaria parasites.
Cap-domain closure enables diverse substrate recognition by the C2-type haloacid dehalogenase-like sugar phosphatase Plasmodium falciparum HAD1.
Structure- and function-based design of Plasmodium-selective proteasome inhibitors.
A novel cyclic GMP-dependent protein kinase is expressed in the ring stage of the Plasmodium falciparum life cycle.
Crystal structures of the carboxyl cGMP binding domain of the Plasmodium falciparum cGMP-dependent protein kinase reveal a novel capping triad crucial for merozoite egress.
Epistasis studies reveal redundancy among calcium-dependent protein kinases in motility and invasion of malaria parasites.
Gametogenesis in malaria parasites is mediated by the cGMP-dependent protein kinase.
Malaria parasite cGMP-dependent protein kinase regulates blood stage merozoite secretory organelle discharge and egress.
Phosphoinositide metabolism links cGMP-dependent protein kinase G to essential Ca(2+) signals at key decision points in the life cycle of malaria parasites.
Phosphoproteomics reveals malaria parasite Protein Kinase G as a signalling hub regulating egress and invasion.
Spatiotemporal and functional characterisation of the Plasmodium falciparum cGMP-dependent protein kinase.
Structures of the cGMP-dependent protein kinase in malaria parasites reveal a unique structural relay mechanism for activation.
The malaria parasite cyclic GMP-dependent protein kinase plays a central role in blood-stage schizogony.
The role of two novel regulatory sites in the activation of the cGMP-dependent protein kinase from Plasmodium falciparum.
cGMP Binding Domain D Mediates a Unique Activation Mechanism in Plasmodium falciparum PKG.
Disruption of a Plasmodium falciparum cyclic nucleotide phosphodiesterase gene causes aberrant gametogenesis.
Guanylyl cyclase activity associated with putative bifunctional integral membrane proteins in Plasmodium falciparum.
The gametocyte-activating factor xanthurenic acid stimulates an increase in membrane-associated guanylyl cyclase activity in the human malaria parasite Plasmodium falciparum.
Pyruvate kinase from Plasmodium falciparum: Structural and kinetic insights into the allosteric mechanism.
Shape change in the receptor for gliding motility in Plasmodium sporozoites.
Biochemical and structural characterization of Plasmodium falciparum glutamate dehydrogenase 2.
The crystal structure of superoxide dismutase from Plasmodium falciparum.
Differences in erythrocyte receptor specificity of different parts of the Plasmodium falciparum reticulocyte binding protein homologue 2a.
Dramatic difference in diversity between Plasmodium falciparum and Plasmodium vivax reticulocyte binding-like genes.
Identification of proteins from Plasmodium falciparum that are homologous to reticulocyte binding proteins in Plasmodium vivax.
Phenotypic variation of Plasmodium falciparum merozoite proteins directs receptor targeting for invasion of human erythrocytes.
Plasmodium falciparum merozoite invasion is inhibited by antibodies that target the PfRh2a and b binding domains.
Variation in the expression of a Plasmodium falciparum protein family implicated in erythrocyte invasion.
Comparison of ligand binding and conformational stability of human calmodulin with its homolog from the malaria parasite Plasmodium falciparum.
Binding of alpha,alpha-disubstituted amino acids to arginase suggests new avenues for inhibitor design.
Crystal structure of arginase from Plasmodium falciparum and implications for L-arginine depletion in malarial infection.
Structural metal dependency of the arginase from the human malaria parasite Plasmodium falciparum.
The activity of Plasmodium falciparum arginase is mediated by a novel inter-monomer salt-bridge between Glu295-Arg404.
Toxoplasma gondii immune mapped protein 1 is anchored to the inner leaflet of the plasma membrane and adopts a novel protein fold.
Structures of P. falciparum protein kinase 7 identify an activation motif and leads for inhibitor design.
Antimalarial Benzoxaboroles Target Plasmodium falciparum Leucyl-tRNA Synthetase.
Adenylate kinase and GTP:AMP phosphotransferase of the malarial parasite Plasmodium falciparum. Central players in cellular energy metabolism.
Subcellular localization of adenylate kinases in Plasmodium falciparum.
The crystal structures of macrophage migration inhibitory factor from Plasmodium falciparum and Plasmodium berghei.
Crystal structure of soluble domain of malaria sporozoite protein UIS3 in complex with lipid.
Structural determinants of the catalytic mechanism of Plasmodium CCT, a key enzyme of malaria lipid biosynthesis.
Malaria parasite tyrosyl-tRNA synthetase secretion triggers pro-inflammatory responses.
Reaction hijacking of tyrosine tRNA synthetase as a new whole-of-life-cycle antimalarial strategy.
A metal ion-dependent conformational switch modulates activity of the Plasmodium M17 aminopeptidase.
Bestatin-based chemical biology strategy reveals distinct roles for malaria M1- and M17-family aminopeptidases.
Structure of the Plasmodium falciparum M17 aminopeptidase and significance for the design of drugs targeting the neutral exopeptidases.
Synthesis and structure-activity relationships of phosphonic arginine mimetics as inhibitors of the M1 and M17 aminopeptidases from Plasmodium falciparum.
Two-pronged attack: dual inhibition of Plasmodium falciparum M1 and M17 metalloaminopeptidases by a novel series of hydroxamic acid-based inhibitors.
X-ray crystal structures of an orally available aminopeptidase inhibitor, Tosedostat, bound to anti-malarial drug targets PfA-M1 and PfA-M17.
Structural and functional insights into the malaria parasite moving junction complex.
Structure and dynamics of apical membrane antigen 1 from Plasmodium falciparum FVO.
Structure of AMA1 from Plasmodium falciparum reveals a clustering of polymorphisms that surround a conserved hydrophobic pocket.
Structure of an IgNAR-AMA1 complex: targeting a conserved hydrophobic cleft broadens malarial strain recognition.
Structure of the malaria antigen AMA1 in complex with a growth-inhibitory antibody.
Structure-Based Identification and Functional Characterization of a Lipocalin in the Malaria Parasite Plasmodium falciparum.
Structural basis for discriminatory recognition of Plasmodium lactate dehydrogenase by a DNA aptamer.
Plasmodium falciparum Apn1 homolog is a mitochondrial base excision repair protein with restricted enzymatic functions.
Structural basis of malaria RIFIN binding by LILRB1-containing antibodies.
Inhibition of protein N-myristoylation blocks Plasmodium falciparum intraerythrocytic development, egress and invasion.
Crystal structure of plasmoredoxin, a redox-active protein unique for malaria parasites.
Structural models for the protein family characterized by gamete surface protein Pfs230 of Plasmodium falciparum.
Crystal structure of P. falciparum Cpn60 bound to ATP reveals an open dynamic conformation before substrate binding.
Characterization of a new phosphatase from Plasmodium.
Biophysical analysis of Plasmodium falciparum Hsp70-Hsp90 organising protein (PfHop) reveals a monomer that is characterised by folded segments connected by flexible linkers.
Characterisation of the Plasmodium falciparum Hsp70-Hsp90 organising protein (PfHop).
Plasmodium falciparum Hop (PfHop) Interacts with the Hsp70 Chaperone in a Nucleotide-Dependent Fashion and Exhibits Ligand Selectivity.
Structural studies of the Hsp70/Hsp90 organizing protein of Plasmodium falciparum and its modulation of Hsp70 and Hsp90 ATPase activities.
A Plasmodium falciparum homologue of Plasmodium vivax reticulocyte binding protein (PvRBP1) defines a trypsin-resistant erythrocyte invasion pathway.
A processing product of the Plasmodium falciparum reticulocyte binding protein RH1 shows a close association with AMA1 during junction formation.
Antibodies targeting the PfRH1 binding domain inhibit invasion of Plasmodium falciparum merozoites.
Reticulocyte binding protein homologues are key adhesins during erythrocyte invasion by Plasmodium falciparum.
Reticulocyte-binding protein homologue 1 is required for sialic acid-dependent invasion into human erythrocytes by Plasmodium falciparum.
Triggers of key calcium signals during erythrocyte invasion by Plasmodium falciparum.
Two Plasmodium rhomboid proteases preferentially cleave different adhesins implicated in all invasive stages of malaria.
Atomic resolution crystal structure of glutaredoxin 1 from Plasmodium falciparum and comparison with other glutaredoxins.
Structural mapping of the ClpB ATPases of Plasmodium falciparum: Targeting protein folding and secretion for antimalarial drug design.
Apicomplexan UCHL3 retains dual specificity for ubiquitin and Nedd8 throughout evolution.
Characterization and structural studies of the Plasmodium falciparum ubiquitin and Nedd8 hydrolase UCHL3.
Nedd8 hydrolysis by UCH proteases in Plasmodium parasites.
Substrate filtering by the active site crossover loop in UCHL3 revealed by sortagging and gain-of-function mutations.
Structural insights into the inactive subunit of the apicoplast-localized caseinolytic protease complex of Plasmodium falciparum.
Dimerization of Arginyl-tRNA Synthetase by Free Heme Drives Its Inactivation in Plasmodium falciparum.
A multistage antimalarial targets the plasmepsins IX and X essential for invasion and egress.
Dual Plasmepsin-Targeting Antimalarial Agents Disrupt Multiple Stages of the Malaria Parasite Life Cycle.
Structures of plasmepsin X from Plasmodium falciparum reveal a novel inactivation mechanism of the zymogen and molecular basis for binding of inhibitors in mature enzyme.
Characterisation of a sexual stage-specific gene encoding ORC1 homologue in the human malaria parasite Plasmodium falciparum.
Expression and characterization of human malaria parasite Plasmodium falciparum origin recognition complex subunit 1.
Plasmodium falciparum origin recognition complex subunit 1 (PfOrc1) functionally complements Deltasir3 mutant of Saccharomyces cerevisiae.
Regulation of Plasmodium falciparum Origin Recognition Complex subunit 1 (PfORC1) function through phosphorylation mediated by CDK-like kinase PK5.
Distinct protein classes including novel merozoite surface antigens in Raft-like membranes of Plasmodium falciparum.
Discovery of a PCAF Bromodomain Chemical Probe.
Structures of three MORN repeat proteins and a re-evaluation of the proposed lipid-binding properties of MORN repeats.
A central role for P48/45 in malaria parasite male gamete fertility.
Pfs47, paralog of the male fertility factor Pfs48/45, is a female specific surface protein in Plasmodium falciparum.
The human malaria parasite Pfs47 gene mediates evasion of the mosquito immune system.
Structural and functional attributes of malaria parasite diadenosine tetraphosphate hydrolase.
Acta Crystallogr Sect F Struct Biol Cryst Commun
Acta Crystallogr. F Struct. Biol. Commun.
Structure of the conserved hypothetical protein MAL13P1.257 from Plasmodium falciparum.
Identification of biochemically distinct properties of the small ubiquitin-related modifier (SUMO) conjugation pathway in Plasmodium falciparum.
The human malaria parasite Plasmodium falciparum has distinct organelle-specific lipoylation pathways.
Disrupting the Allosteric Interaction between the Plasmodium falciparum cAMP-dependent Kinase and Its Regulatory Subunit.
Discovery of new non-pyrimidine scaffolds as Plasmodium falciparum DHFR inhibitors by fragment-based screening.
Biochemical and functional analysis of two Plasmodium falciparum blood-stage 6-cys proteins: P12 and P41.
Structural and biochemical characterization of Plasmodium falciparum 12 (Pf12) reveals a unique interdomain organization and the potential for an antiparallel arrangement with Pf41.
Gene disruption of Plasmodium falciparum p52 results in attenuation of malaria liver stage development in cultured primary human hepatocytes.
Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design.